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Abstract
Background: Immunization information systems (IISs) are electronic registries used to monitor individual vaccination
status and assess vaccine coverage. IISs are currently not widely used across Canada, where health jurisdictions
employ a range of approaches to capture influenza immunization information. Conducted in advance of the 2009
H1N1 vaccination campaign, the objectives of this study were to understand the perceived value of individual-level
data and IISs for influenza control, identify ideal system functions, and explore barriers to implementation.
Methods: In July and August 2009, semi-structured interviews were conducted with key informants engaged in
vaccine delivery and/or pandemic planning at regional, provincial/territorial and federal levels across Canada. Key
informants were recruited using a combination of convenience and snowball sampling methodologies. Qualitative
analysis was used to extract themes from interview content.
Results: Patient management, assessment of vaccine coverage, and evaluation of safety and effectiveness were
identified as public health priorities that would be achieved in a more timely manner, and with greater accuracy,
through the use of an IIS. Features described as ideal included system flexibility, rapid data entry, and universality.
Financial and human resource constraints as well as coordination between immunization providers were expressed
as barriers to implementation.
Conclusions: IISs were perceived as valuable by key informants for strengthening management capacity and
improving evaluation of both seasonal and pandemic influenza vaccination campaigns. However, certain
implementation restrictions may need to be overcome for these benefits to be achieved.
Background
Immunization information systems (IISs) are electronic
registries containing individual-level vaccination infor-
mation, usually including additional functionalities such
as adverse event reporting, linkage with other electronic
registries, or vaccine management [1], and are used to
monitor individual vaccination status and assess vaccine
coverage. Individual-level data collected in electronic
form at the point of influenza immunization provide
public health practitioners, planners and clinicians with
readily accessible, high-quality information with which
to make decisions [2].
User perceptions of electronic patient information sys-
tems have been studied broadly [3-7]; however, this
research has primarily focused on the experiences and
insights of front-line care providers. Vaccination program
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sionals all rely on immunization data, but little is known
about these users’ perceptions of IISs for influenza
vaccination.
Canadian jurisdictions employ a range of approaches
to capture seasonal influenza immunization information,
including full IISs, physician billing records, paper sys-
tems that maintain information in paper format either
in aggregate form or at an individual level, and hybrid
systems in which paper immunization records are trans-
ferred to an electronic database. In advance of the pan-
demic (H1N1) 2009 influenza vaccination campaign, we
were interested in learning about the perspectives of
individuals from jurisdictions with access to IISs as well
as those from jurisdictions employing less comprehen-
sive data collection methods. In this study we explored
the perceptions of key informants from influenza vacci-
nation programs at federal, provincial/territorial and
regional levels, and we sought to answer the following
questions: (1) What are the perceived benefits of collect-
ing individual-level data, for pandemic, as well as seaso-
nal influenza immunization? (2) Which features and
functionalities should an ideal immunization informa-
tion system encompass? (3) What are the perceived bar-
riers to collecting individual-level data? (4) What are the
perceived barriers to achieving an ideal IIS?
Methods
Sampling and recruitment
The breadth of information that was sought in this
study led us to identify key informants engaged in vac-
cine delivery and/or pandemic planning in regional,
provincial/territorial and federal jurisdictions. To
ensure that the findings reflected perspectives from
across Canada, recruitment was initiated by approach-
ing members of a national committee representing all
thirteen provinces and territories, as well as federal
bodies, who are working towards creating a national
network of immunization registries. These members
were approached electronically, through a recruitment
email requesting their participation in a telephone
interview. Snowball sampling was used to recruit addi-
tional participants by asking interviewees to provide
names of other individuals in their jurisdiction
involved with pandemic planning, vaccine program
development and/or vaccine delivery. Recruitment of
participants continued until broad geographic repre-
sentation had been achieved to the extent possible
given the limited availability of our target population
during a pandemic period. Ethics approval was granted
by the University of Toronto’s Health Sciences
Research Ethics Board.
Data collection
A semi-structured approach to data collection was cho-
sen in order to focus each interview session on particu-
lar topic areas while providing an opportunity for
broader participant insights to be expressed during the
course of the dialogue. Key questions were developed by
the research team based on study objectives. All inter-
views were conducted over the telephone by one mem-
ber of the research team, and recorded with an
electronic voice-recorder once consent was obtained.
Recordings were transcribed verbatim by an external
transcriptionist for analysis purposes.
Data analysis
Interview data were assessed using conventional content
analysis. This approach allows categories and ultimately
themes within the data to be discerned [8,9]. Following
immersion in the data through reading the transcripts
and listening to interview recordings, two members of
the research team independently coded interview tran-
scripts. Throughout this process they developed a cod-
ing structure, which defined codes and described the
relationship between codes and sub-codes when applic-
able; this structure evolved as necessary to capture new
and modified codes. Periodic co-coding, whereby some
transcripts were coded by both team members, as well
as regular meetings between the coders, ensured contin-
ued consistency in creation and application of codes.
Approximately 15% of transcripts were co-coded. Dis-
agreement with respect to coding was rare and was
resolved through discussion to reach consensus regard-
ing both the definition and scope of the code. Once
coding was completed, the codes were imported into
qualitative analysis software (QSR NVivo Version 8.0).
Informed by the study questions and designed based on
trends that were identified through the coding process
(an approach both deductive and inductive), a series of
queries was created and executed in order to examine,
sort, and categorize and the coded text. From these ana-
lyses, key themes in the data emerged. Consensus
regarding the key themes was reached between the two
coders, after which two verification phases were com-
pleted: (1) The themes were first reviewed by a team
member who had not participated in the coding process
but who was familiar with all of the interview transcripts
in order to corroborate the findings. (2) Further, obser-
ving a process called member checking [10], key infor-
mants were asked to review a summary of the themes in
order to ascertain the validity of the interpretations.
Twelve participants responded to this request, and all
indicated that the findings reflected their recollection of
the interview content.
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A total of 31 telephone interviews were conducted dur-
ing July and August 2009. When participants were
approached for approval to include their interview data
in an analysis for publication, however, five participants
declined this request. The findings presented here reflect
26 interviews conducted with 29 participants (three
interviews were conducted with more than one indivi-
dual); 19 of these participants were recruited through
snowball sampling. Saturation was reached before the
end of the interview process; no new categories or
themes were identified after the 13
th interview but
because of our desire for geographic representation we
continued recruitment until this had been achieved.
Respondents included community health nurses, infec-
tious disease coordinators, vaccine program managers,
epidemiologists, medical officers of health, and other
public health and communicable disease specialists. Par-
ticipants represented nine provinces and two territories
as well as two federal bodies; we were unable to recruit
participants from one province and one territory. The
majority of participants were involved with pandemic
planning, either at a regional, provincial/territorial, or
federal level.
4/26 interviews were conducted with users of electro-
nic information systems that captured all vaccinees, and
4/26 systems used by respondents maintained paper
records of individual-level data. 6/26 participants’ sys-
tems retained aggregate counts of vaccinees, and 10/26
systems captured individual-level data electronically for
certain sub-populations or in certain jurisdictions. Two
respondents had experience with or knowledge about
many different approaches to immunization data
collection.
Perceived benefits of collecting individual-level data
Benefits of individual-level influenza immunization data
expressed by participants included both observed and
envisioned capabilities, depending on whether or not an
interviewee had experience capturing electronic data.
Most participants perceived IISs to be valuable, while a
small number expressed the view that they were of lim-
ited use. The benefits of collecting individual-level
immunization data electronically that were shared by
the largest number of respondents included assessment
of vaccine coverage and patient management. These
were expressed as important strengths for both seasonal
and pandemic influenza vaccination data.
Access to comprehensive vaccination information
within an IIS facilitates in-depth evaluation of vaccine
coverage and immunization programs overall. Respon-
dents explained that individual-level immunization data
allow (or would allow) them to assess progress towards
coverage targets and to create a response plan, if neces-
sary, to improve coverage. Further, access to electronic
immunization data meant that respondents would be
able to engage in more timely analysis and reporting.
I just find it interesting to actually analyze that data
and then use it to see what you can do to - as a tar-
get, you know, to increase your rates...Are we reach-
ing who we want to and those populations defined at
risk?
In terms of generating a report, you could do it much
faster. Because right now we have to physically go
through and count all of these things... In terms of
the reporting and the records and everything else, it
would be a really big time saver.
The added benefit of being able to look at longitudinal
coverage data was also noted.
We found it very valuable over the years because
we’ve been able to determine trends, who’s getting the
vaccine and who isn’t. And that’s allowed us to tar-
get specific risk groups where we feel we need to
improve coverage.
R e s p o n d e n t sf e l tt h a tm a i n t aining electronic immuni-
zation records allowed them to better manage patient
care both at the point of vaccination and during subse-
quent patient visits. Immunization records that were
accessible to other providers were thought to further
improve clinical care.
When there’s an immunization registry present, if
somebody goes to enter the information, they know
that that person’s had an adverse event ‘cause it’s
flagged automatically. So they know not to immunize
that individual.
We had people coming to our health unit saying,
“...They won’t let me come to work unless I have
proof.” We would go through boxes of paper consents...
and then retrieve that information manually. Now it’s
just a couple of keyboard clicks and we’re there.
The ability to record and track dose number was iden-
tified by a large proportion of respondents as an impor-
tant feature of IISs during a pandemic immunization
campaign. (When the interviews were conducted it was
believed that a two-dose schedule would be required for
all individuals.) Respondents felt strongly about the need
to have accessible information at the point of service to
assess a client’s prior vaccination history and provide
the appropriate service, observing the need to properly
space doses in order to ensure effectiveness.
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whatever they determine, 21, you know, 28 days
apart, then to ensure that the time period is accu-
rate, that would be important. Because otherwise
you’re depending on that individual to come back
when they’re supposed to and, you know, that often
doesn’t work.
Other perceived benefits of the collection of indivi-
dual-level data were expressed by fewer participants.
Some respondents described the importance of monitor-
ing adverse events following immunization, especially in
the context of a new vaccine containing an adjuvant,
and felt that IISs are/would be particularly useful for
this, although others noted that it was possible to moni-
tor adverse events without individual-level immunization
data. Facilitating the evaluation of vaccine effectiveness
through the availability of definitive information about
who had been vaccinated and who had not was also
expressed as a benefit of an IIS, as was improved effi-
ciency at the point of care.
Two respondents pointed out that there are many
unknowns associated with a pandemic - including a new
vaccine - and explained that the greater the availability
of individual-level data, the more in-depth the analyses
that could be conducted when and if needed.
With pandemic vaccine there’s so much that we don’t
know about it. We don’tk n o ww i l lw eh a v eal o to f
a d v e r s er e a c t i o n s ,w i l lw eh a v ee n o u g ht og i v et w o
doses immediately, will we have to recall later when
we have some more vaccine available... So I feel it’s
almost more crucial to have the individual informa-
tion with pandemic than it is with seasonal
influenza.
A small number of participants felt that the increased
effort required to collect individual-level data did not
outweigh the benefits, and that resources would be
more appropriately applied to other elements of the vac-
cination program. Assuming that individual-level data
would have to be collected and captured electronically
in two separate phases (which, depending on the type of
system, is not necessarily true), they believed that staff
time could be better spent engaged in clinical work.
Another individual was appreciative of the value of IISs,
but cautioned that: “You have to be careful that, you
know, the management of the system doesn’to u t w e i g h
what you can actually get out of it.”
Features of an optimal system
It was important to understand which system features
would allow key informants to realize the benefits of
IISs. Prior to each interview, participants were provided
with a proposed set of critical and optional IIS function-
alities about which we requested feedback during the
interview. Responses described in the following section
were based on participants’ experiences and supplemen-
ted with reactions to this list. Again depending on
experience, respondents described features of current
systems that were already performing well, or desired
characteristics that they perceived as critical to achieving
an ideal IIS.
Many key informants described the same several fea-
tures and functionalities as important for an optimal IIS;
system flexibility, rapidity of data capture, and universal-
ity were common themes. System portability and wide-
spread accessibility were identified as being key to
facilitate consistency of reporting in a range of immuni-
zation settings. Web-based systems, as well as systems
that could operate in a disconnected mode and subse-
quently be reintegrated with the central system, were
viewed as advantageous for maintaining comprehensive
patient registries.
[What] stands out right away for me is portability,
the ability to take that system into remote areas or,
you know, school gymnasiums and be able to use
that system.
The operation in the disconnected mode is essential
because, you know, like, when you look at our rural
population in [province], we do many clinics out in
the rural areas and it’s really necessary to have that.
Reporting functionalities were critical to key infor-
mants, and many mentioned the value of customizable
reporting software. In addition, rapid, efficient data col-
lection and entry was an important consideration for
respondents. Features mentioned included pre-populated
data fields and bar-code scanning of lot number and cli-
ent health insurance cards. Lastly, the availability of
real-time or close to real-time data was described as
ideal by several key informants.
Obviously it’d have to be easy..., a swipe of the health
card, you know, to populate demographics, those
kinds of things. I think it’s really important that it be
quick because where you often get your bottleneck is
r i g h ta tt h er e g i s t r a t i o nd e s k . . .I th a st ob ea b l et o
generate reports, those reports that the Ministry
requires.
We want to be able to look and see how we’re doing
on an ongoing basis, not just quarterly or whatever...
I really think it’s important to have real-time connec-
tivity to a central database.
Many key informants felt that a universal IIS would be
of high value both to vaccine administrators as well as
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a national IIS, while others e x p l a i n e dt h a te v e nas t a n -
dard system within one health region that was used by
all vaccine providers would be an improvement. Uni-
versality would allow consistency of immunization
records to be maintained to accommodate patients who
relocate, and would also permit broader and more com-
prehensive analyses, including cross-jurisdictional cover-
age assessment. IISs that were either integrated with or
could be linked to other health registries or full electro-
nic health records were mentioned as being particularly
ideal.
Whatever the system is, everybody that has access to
the vaccine needs to be reporting in the same way, in
real time.
People move around and so it would be very helpful
to have something that you could really track people,
people’s immunization no matter where they are and
you’dg e tm u c hb e t t e r – higher quality information if
you had it all in one place.
The biggest shortcoming right now is that our vacci-
nation system is not integrated with the client’s
health record. That’s the number one thing. If we
could have all the information we currently collect
related to vaccination but have that as a part of
the– one client, one health record concept.
Additional features that were described by a small
number of respondents as being ideal included clinic
and inventory management components, reminder tools,
flags for missed doses and previous reactions, and the
ability to print off immunization records.
Barriers to implementation
While respondents described many benefits of collecting
individual-level immunization data, few public health
jurisdictions in the country rely exclusively on IISs for
influenza vaccination data collection. Many use IISs or
other registries to capture data for certain populations
but the capacity of these jurisdictions to assess coverage
and conduct other program evaluation exercises is lim-
ited. Interview informants consistently described the
same key barriers to the implementation and operation
of an ideal IIS.
Financial and human resource constraints were identi-
fied as barriers by the majority of respondents. Although
these constraints were often mentioned generally, many
respondents went on to describe system elements that
would be particularly resource-intensive. These included
the requisite hardware and software, the combination of
clinical and technological expertise required to develop
and manage an IIS, and the intensity of staff training
t h a tw o u l dh a v et ob ei n v o l v e dt oe n s u r et h a t
individuals with clinical responsibilities could interface
with the IIS appropriately. The difficulty and expense of
ensuring continual remote system access for on-going
data collection was also mentioned as a barrier.
It’s hard for me to picture even having that level of
information put into an electronic system only
because of the amount of PCs that would be needed
and the amount of staff training, you know, to get
that together. It’s a lot easier to have someone
trained how to fill in a piece of paper ...and it
requires a lot less dollar input.
Very few people who know a lot about immunization
and a lot about what happens on the front lines and
a lot about what analysis could be done, are comfor-
table enough with the IT components that are
required... Similarly, on the IT or the vendor side,
they often understand so poorly how immunization
works and how the information will be analyzed,
they themselves have no idea whether what they’re
offering makes sense or not. And there’san e e dt o
have people who can serve to translate between the
two groups and there aren’t– there just aren’tv e r y
many people like that in the system.
Some respondents expressed concern about competing
financial and political priorities within their jurisdictions.
Investing time and resources to develop and implement a
new IIS, especially when a national system may be forth-
coming, can be difficult to justify. (A new public health
system with IIS functionality is being developed in Canada,
and while it is anticipated that this system - Panorama -
will meet some of the immunization surveillance criteria
that are presented here, few details regarding time to
implementation are publicly available at the time of this
paper’s drafting.) Among the participants who felt more
strongly about the value of IISs for pandemic influenza
than for seasonal, some had trouble with the idea of devot-
ing the resources that would be required toward some-
thing that would be most useful for a relatively short
period of time.
I think that the bulk of the funding towards immuniza-
tion has always been towards purchasing of vaccines
and just distributing it. And not a lot of thought’s been
put to monitoring the records and monitoring coverage.
I think that it’s just not been a priority. Unfortunately,
Panorama, which would have been the answer because
it would be a single type of registry that could have
been modified across the country for all– and accessible
to all provinces and territories, I’m not sure if it’s going
to meet all of the requirements.
To implement a new system needs a lot of adjust-
ment and a lot of preparation. I think if it’sd o n e
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resources and extremely high level of emergency, like,
pandemic immunization, it adds to the difficulty...
Patient privacy and confidentiality were identified by
several respondents as important issues that must be
considered; personal health information legislation -
especially when it differs across jurisdictions - may
make the implementation of an IIS difficult, or may
mean that data may only legally be shared with certain
parties. Consent laws in some jurisdictions may limit
the accessibility of patient data for linkage or analysis.
It’s certainly the privacy and confidentiality. I hate
saying that they’re barriers but they– b u ti ti s ,i na
way...There are criteria that have to be met in order
for them to agree to allow us to populate this data-
base that we’re trying to develop. So we have to meet
those regulations.
As it stands we cannot have access to the health
insurance database where we would have a common
denominator and after it would be easier to put into
[immunization registry], b u ti tc a n n o tf o rt h et i m e
being work this way...Because of individual consent
laws. It’s very sensitive.
The last barrier to the implementation of an IIS
described by study participants is the fact that in some
jurisdictions multiple providers administer influenza
vaccines. Key informants pointed out that some provi-
ders have no incentive to collect electronic individual-
level immunization information, or may not be willing
to share their data or to report into a shared electronic
system. Even with acceptance by all providers, ensuring
that a system is compatible across the full range of
health systems in a jurisdiction is challenging.
We are not the biggest provider of flu vaccine in
terms of– who gives the actual immunizations...pri-
mary care providers and other agencies are. And
they’re notoriously bad for giving information...We
have many different systems going on here...you have
one hospital system, the physicians are probably look-
ing at an electronic record. We’re looking at Panor-
ama in public health ...Would there be some way of
coordinating so that we’d be one?
Discussion
In recent years there has been a strong push in Canada
for the establishment of electronic health records
[11,12], and while the country is moving in the direction
of a network of provincial/territorial electronic patient
registries, the completion of t h e s er e g i s t r i e si sl i k e l y
many years in the future. Findings from this study sug-
gest that the immunization component of these regis-
tries will be welcomed by and useful to many public
health planners and decision-makers, and that the
implementation of systems that permit individual-level
influenza immunization information to be captured elec-
tronically in the interim would be valuable. Key benefits
of collecting data at this level of granularity using an
electronic platform as expressed by participants in this
study include assessment of vaccine coverage across a
range of population groups, care management, and
rapid availability of data for reporting and analysis.
There are important distinctions between the collec-
tion of individual-level data and a full IIS [1], and in
this study we were interested in experiences with and
perceptions of both. We observed that the perceived
potential usefulness and barriers to implementation vary
depending on the approach to data collection that an
individual knows of or has experienced. Participants
familiar with collection of information on paper fol-
lowed by manual entry into an electronic system (cur-
rently a common approach in Canada) were concerned
about how time consuming this process could be and
were supportive of system features that would expedite
data entry. In contrast, some systems are fully electronic
at the point of care and although this implies intensive
infrastructure requirements (a computer at every regis-
tration and nursing station, for example), it also reduces
data entry requirements considerably while providing
real-time or close to real-time access to data. Depending
on the population size and resources of a particular jur-
isdiction, the appropriateness of these approaches will
vary.
Patient privacy was an important theme that emerged
as a barrier to a comprehensive IIS. While it varies by
province and territory, privacy legislation in Canada
appropriately limits which parties can be custodians of
personal health information, and this may mean that
individual-level data cannot be shared with particular
groups. Further, in order to build a more complete
health profile for clients, immunization data from multi-
ple providers must be linked to a common file. To
accomplish this, a unique identifier must be sufficiently
widely used to be attached to records in multiple envir-
onments but adequately flexible to be used across these
environments with the appropriate privacy controls.
With a growing commitment to the establishment of
comprehensive patient registries these are not insur-
mountable challenges; linkage can be carried out by par-
ties with the authorization to possess personal health
information, and de-identified datasets and aggregated
data can then be shared among other public health
users. When data are required for research purposes,
however, navigating multiple jurisdictions’ data sharing
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when patients have given consent for their health infor-
mation to be used in this way [13].
Lack of common interest in collecting individual-level
influenza immunization data and data sharing between
public health organizations and other vaccination provi-
ders were perhaps the most daunting barriers to the
implementation of complete, electronic immunization
records revealed by respondents. This is especially chal-
lenging in jurisdictions where the majority of vaccina-
tions are administered by community physicians.
Participants explained that it is often very difficult to
obtain vaccination information from primary care provi-
ders (even when this data is recorded electronically),
which makes accurate assessment of vaccine coverage
nearly impossible. However, these barriers have been
overcome in many jurisdictions globally [14-18], as well
as within Canada [19,20], through the development of
provincial, state and national registries that are designed
to receive data from multiple providers. In some areas,
financial incentives have been helpful to encourage data
sharing; for example, in Australia an ‘information incen-
tive’ is offered to all vaccine providers who report com-
pleted vaccination schedules to the Australian
Childhood Immunisation Register [16].
Limitations
As a result of our sampling approach, the individuals we
recruited were almost all representatives of public health
organizations. It would be valuable to gain insights into
the perspectives of primary care practitioners and other
vaccine administrators. Further, because our original
sample comprised members of a committee working
towards creating a national network of immunization
registries, it is not surprising that these individuals were
supportive of the collection of individual-level influenza
immunization data. Other key informants to whom we
were referred by the initial respondents - and who made
up the majority of the study population - were not part
of this network, however, and thus provided a more
balanced perspective. Nevertheless, we acknowledge that
this sampling approach may have introduced bias into
the work.
This work was conducted between the first and sec-
ond waves of an influenza pandemic, and results may
have been different if we had not interviewed at a time
when there was an increased sense of urgency related to
immunization data. Likely due in part to the timing of
our research, we were unable to recruit participants
from two jurisdictions. Respondents from these areas
would have added unique and valuable perspective to
this work. Further, although they initially consented to
contribute to this research as key informants, five indivi-
duals from provincial and federal immunization
programs declined our request to include their inter-
views in this analysis. However, other representation
from these jurisdictions was included in the analysis.
Conclusions
Further research is required to evaluate whether there is
a link between detailed influenza immunization record-
keeping and improved health outcomes. Based on the
perceived benefits revealed by this work, however, we
recommend that health jurisdictions across Canada con-
sider supporting the implementation of mechanisms to
electronically capture individual-level influenza immuni-
zation data, and work to improve dialogue between pub-
lic health and other vaccine providers regarding the
collection and sharing of immunization information.
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